Clinical trials
catalyst calendar across sponsors →Studies where CBLL is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional · 3 observational
Held by 10 tracked-famous managers (MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, D. E. Shaw & Co., Inc., TWO SIGMA INVESTMENTS, LP, +5 more) · FINRA short interest 5.5 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 11 sells · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| EEG Abnormalities in Adult ICU Patients With High Risk of DeliriumNCT07485244observationalPrevalence of EEG Abnormalities on the Ceribell EEG System | — | Recruiting | Device: Ceribell EEG System | Delirium in the Intensive Care Unit | 100 | 2026-12-31 | in 134 d | 2026-04-21 |
| Ceribell Delirium Monitor Outcomes Pilot StudyNCT07449416Proportion of Participants with Delirium Diagnosed Outside Routine Standard-of-Care AssessmentsNon-randomized · Open-label · Screening | Not applicable | Recruiting | Device: Ceribell Delirium Monitoring System | Delirium in the Intensive Care Unit | 100 | Oct 2026 | ≤ 73 d | 2026-07-22 |
| Ceribell Delirium Data Collection StudyNCT04962815observationalPerform Confusion Assessment Method for the ICU (CAM-ICU) assessment | — | Recruiting | Device: Electroencephalogram (EEG) Test | Delirium | 200 | 2025-12-31 | — | 2025-07-25 |
| Does Use of Rapid Response EEG Impact Clinical Decision MakingNCT03534258observationalChange in physicians' diagnosis decision | — | Completed | Device: Ceribell Rapid Response EEG, Survey | Nonconvulsive Status Epilepticus, Seizures | 164 | 2019-04-30actual | — | 2019-08-20 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19